非布司他2020价格
(Alias: Febuxostat) is a new type of xanthine oxidase inhibitor that reduces blood uric acid levels by reducing uric acid production.
In February 2009, febuxostat was approved by the US FDA for the treatment of gout in adults.
In 2013, febuxostat was launched in China for the treatment of chronic hyperuricemia (gout). What is the price of febuxostat in 2020?
Price of Febuxostat: It is understood that the price of Febuxostat on the domestic market is relatively expensive and is not suitable for patients to take it for a long time. What I need to tell you here is that the efficacy of Febuxostat produced by Zydus Pharmaceutical Factory in India is the same as that of the original drug. The price is indeed much lower. The specification is 80mg*30 tablets/box. Its price is about 200$. Due to the floating exchange rate, the price is different. Please consult the medical companion for the specific price!
Here are some things you need to know about using febuxostat:
The recommended initial dose of febuxostat is 40 mg once a day (some foreign instructions recommend a starting dose of 20 mg, once a day). After taking the drug for 2 to 5 weeks, recheck the blood uric acid. Gradually increase the dosage according to the blood uric acid value, with each increment of 20 mg. The maximum daily dose is 80 mg. After the blood uric acid value reaches the target, maintain the lowest effective dose. Food and antacids have no effect on taking the medicine.
In the early stages of treatment, the rapid decrease in blood uric acid levels may cause more urate deposited in tissues to be mobilized, leading to an increase in the frequency of gout attacks.
Patients with acute attacks of gout need to control gout symptoms before use. If gout attacks occur during treatment with febuxostat, there is no need to discontinue treatment with febuxostat. Gout should be treated accordingly based on the specific circumstances of the attack.
Recommended related hot articles: /newsDetail/74585.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)